Mendelian randomisation study of smoking, alcohol, and coffee drinking in relation to Parkinson’s Disease

C. Domenighetti; P-E Sugier; A.A.K. Sreelatha; C. Schulte; S. Grover; O. Mohamed; B. Portugal; P. May; D.R. Bobbili; M. Radivojkov-Blagojevic; P. Lichtner; A.B. Singleton; D.G. Hernandez; C. Edsall; G.D. Mellick; A. Zimprich; W. Pirker; E. Rogaeva; A.E. Lang; S. Kõks; P. Taba; S. Lesage; A. Brice; J-C Corvol; M-C Chartier-Harlin; E. Mutez; K. Brockmann; A.B. Deutschländer; G.M. Hadjigeorgiou; E. Dardiotis; L. Stefanis; A.M. Simitsi; E.M. Valente; S. Petrucci; S. Duga; L. Straniero; A. Zecchinelli; G. Pezzoli; L. Brighina; C. Ferrarese; G. Annesi; A. Quattrone; M. Gagliardi; H. Matsuo; Y. Kawamura; N. Hattori; K. Nishioka; S.J. Chung; Y.J. Kim; P. Kolber; B.P.C. van de Warrenburg; B.R. Bloem; J. Aasly; M. Toft; L. Pihlstrøm; L.C. Guedes; J.J. Ferreira; S. Bardien; J. Carr; E. Tolosa; M. Ezquerra; P. Pastor; M. Diez-Fairen; K. Wirdefeldt; N.L. Pedersen; C. Ran; A.C. Belin; A. Puschmann; C. Hellberg; C.E. Clarke; K.E. Morrison; M. Tan; D. Krainc; L.F. Burbulla; M.J. Farrer; R. Krüger; T. Gasser; M. Sharma; A. Elbaz

doi:10.3233/JPD-212851

Back

Mendelian randomisation study of smoking, alcohol, and coffee drinking in relation to Parkinson’s Disease

Journal article

Peer reviewed

Mendelian randomisation study of smoking, alcohol, and coffee drinking in relation to Parkinson’s Disease

C. Domenighetti, P-E Sugier, A.A.K. Sreelatha, C. Schulte, S. Grover, O. Mohamed, B. Portugal, P. May, D.R. Bobbili, M. Radivojkov-Blagojevic, …

Journal of Parkinson's Disease, Vol.12(1), pp.267-282

2022

DOI: https://doi.org/10.3233/JPD-212851

Files and links (1)

url

Link to Published Version *Subscription may be requiredView

Abstract

Background:Previous studies showed that lifestyle behaviors (cigarette smoking, alcohol, coffee) are inversely associated with Parkinson’s disease (PD). The prodromal phase of PD raises the possibility that these associations may be explained by reverse causation. Objective:To examine associations of lifestyle behaviors with PD using two-sample Mendelian randomisation (MR) and the potential for survival and incidence-prevalence biases. Methods:We used summary statistics from publicly available studies to estimate the association of genetic polymorphisms with lifestyle behaviors, and from Courage-PD (7,369 cases, 7,018 controls; European ancestry) to estimate the association of these variants with PD. We used the inverse-variance weighted method to compute odds ratios (ORIVW) of PD and 95%confidence intervals (CI). Significance was determined using a Bonferroni-corrected significance threshold (p = 0.017). Results:We found a significant inverse association between smoking initiation and PD (ORIVW per 1-SD increase in the prevalence of ever smoking = 0.74, 95%CI = 0.60–0.93, p = 0.009) without significant directional pleiotropy. Associations in participants ≤67 years old and cases with disease duration ≤7 years were of a similar size. No significant associations were observed for alcohol and coffee drinking. In reverse MR, genetic liability toward PD was not associated with smoking or coffee drinking but was positively associated with alcohol drinking. Conclusion:Our findings are in favor of an inverse association between smoking and PD that is not explained by reverse causation, confounding, and survival or incidence-prevalence biases. Genetic liability toward PD was positively associated with alcohol drinking. Conclusions on the association of alcohol and coffee drinking with PD are hampered by insufficient statistical power.

Details

Title: Mendelian randomisation study of smoking, alcohol, and coffee drinking in relation to Parkinson’s Disease
Authors/Creators: C. Domenighetti (Author/Creator)
P-E Sugier (Author/Creator)
A.A.K. Sreelatha (Author/Creator)
C. Schulte (Author/Creator)
S. Grover (Author/Creator)
O. Mohamed (Author/Creator)
B. Portugal (Author/Creator)
P. May (Author/Creator)
D.R. Bobbili (Author/Creator)
M. Radivojkov-Blagojevic (Author/Creator)
P. Lichtner (Author/Creator)
A.B. Singleton (Author/Creator)
D.G. Hernandez (Author/Creator)
C. Edsall (Author/Creator)
G.D. Mellick (Author/Creator)
A. Zimprich (Author/Creator)
W. Pirker (Author/Creator)
E. Rogaeva (Author/Creator)
A.E. Lang (Author/Creator)
S. Kõks (Author/Creator)
P. Taba (Author/Creator)
S. Lesage (Author/Creator)
A. Brice (Author/Creator)
J-C Corvol (Author/Creator)
M-C Chartier-Harlin (Author/Creator)
E. Mutez (Author/Creator)
K. Brockmann (Author/Creator)
A.B. Deutschländer (Author/Creator)
G.M. Hadjigeorgiou (Author/Creator)
E. Dardiotis (Author/Creator)
L. Stefanis (Author/Creator)
A.M. Simitsi (Author/Creator)
E.M. Valente (Author/Creator)
S. Petrucci (Author/Creator)
S. Duga (Author/Creator)
L. Straniero (Author/Creator)
A. Zecchinelli (Author/Creator)
G. Pezzoli (Author/Creator)
L. Brighina (Author/Creator)
C. Ferrarese (Author/Creator)
G. Annesi (Author/Creator)
A. Quattrone (Author/Creator)
M. Gagliardi (Author/Creator)
H. Matsuo (Author/Creator)
Y. Kawamura (Author/Creator)
N. Hattori (Author/Creator)
K. Nishioka (Author/Creator)
S.J. Chung (Author/Creator)
Y.J. Kim (Author/Creator)
P. Kolber (Author/Creator)
B.P.C. van de Warrenburg (Author/Creator)
B.R. Bloem (Author/Creator)
J. Aasly (Author/Creator)
M. Toft (Author/Creator)
L. Pihlstrøm (Author/Creator)
L.C. Guedes (Author/Creator)
J.J. Ferreira (Author/Creator)
S. Bardien (Author/Creator)
J. Carr (Author/Creator)
E. Tolosa (Author/Creator)
M. Ezquerra (Author/Creator)
P. Pastor (Author/Creator)
M. Diez-Fairen (Author/Creator)
K. Wirdefeldt (Author/Creator)
N.L. Pedersen (Author/Creator)
C. Ran (Author/Creator)
A.C. Belin (Author/Creator)
A. Puschmann (Author/Creator)
C. Hellberg (Author/Creator)
C.E. Clarke (Author/Creator)
K.E. Morrison (Author/Creator)
M. Tan (Author/Creator)
D. Krainc (Author/Creator)
L.F. Burbulla (Author/Creator)
M.J. Farrer (Author/Creator)
R. Krüger (Author/Creator)
T. Gasser (Author/Creator)
M. Sharma (Author/Creator)
A. Elbaz (Author/Creator)
Publication Details: Journal of Parkinson's Disease, Vol.12(1), pp.267-282
Publisher: IOS Press
Identifiers: 991005540324607891
Murdoch Affiliation: Centre for Molecular Medicine and Innovative Therapeutics
Language: English
Resource Type: Journal article

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Metrics

70 Record Views

58 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.52 Neurodegenerative Diseases; 1.52.67 Parkinson's Disease
Web Of Science research areas: Neurosciences
ESI research areas: Neuroscience & Behavior